Results 131 to 140 of about 30,904 (216)

Glycolipid Antibodies in Patients With Chronic Idiopathic Axonal Polyneuropathy and Gluten Neuropathy. [PDF]

Eur J Neurol
Zis P, Artemiadis A, Halstead S, Hadjigeorgiou GM, Willison H, Hadjivassiliou M.   +5 more
europepmc   +1 more source

Mechanism elucidation of cell‐selective fluorescent probes

Smart Molecules, Volume 4, Issue 1, March 2026.
This perspective outlines five mechanistic strategies—Protein‐oriented, carbohydrate‐oriented, lipid‐oriented, gating‐oriented, and metabolism‐oriented live‐cell distinctions—for achieving cell‐selective fluorescence in live‐cell imaging. By classifying probes based on their interactions with proteins, carbohydrates, lipids, transporters, or metabolic ...
Sourav Sarkar, Young‐Tae Chang
wiley   +1 more source

Nanoparticle-assisted structural tailoring of trehalose lipid biosynthesis by <i>Rhodococcus erythropolis</i> WJ-2. [PDF]

RSC Adv
Meng Y, Ou X, Liu Z, Yao S, Hu C, Yu Q, Xia W.   +6 more
europepmc   +1 more source

Lipid Nanoparticles in Drug Delivery: Overcoming Challenges and Unlocking New Frontiers

Small Structures, Volume 7, Issue 3, March 2026.
Lipid nanoparticles (LNPs) have revolutionized nucleic acid delivery, yet challenges in formulation, stability, and targeted efficacy persist. This review explores how advances in microfluidic manufacturing, precision targeting, and endosomal escape are reshaping LNP design.
Jordan Kambanis, Lauren A. Lowe, Jingyi Yao, Zhenxu Yang, Shaoxue Zeng, Ken‐Tye Yong, Ling Zhu, Yi Shen   +7 more
wiley   +1 more source

Ticked Off: Allergic Effector Cells in the Pathogenesis of Alpha-gal Syndrome. [PDF]

Curr Allergy Asthma Rep
Kepley CL, Wang Y, Yelton A, Siebert ER, Iweala OI.   +4 more
europepmc   +1 more source

Trends in Dietary Exosome‐Like Nanoparticles: Preparation, Nutritional Functions, Bioactive Delivery Efficacy, Human Health Effects, and Future Product Development

Small Structures, Volume 7, Issue 3, March 2026.
This graphical abstract summarizes the current advances in dietary exosome‐like nanoparticles (ELNs), highlighting their biogenesis pathways (MVB‐dependent, vacuole‐mediated, and EXPO routes), molecular composition (nucleic acids, lipids, proteins, and bioactive compounds), and major preparation strategies including differential ultracentrifugation ...
Nidesha Randeni, Jinhai Luo, Min‐Hsiung Pan, Baojun Xu   +3 more
wiley   +1 more source

Two‐Dimensional Frameworks From Metal Oxo Clusters at Liquid Interfaces

Small Structures, Volume 7, Issue 3, March 2026.
A two‐dimensional analog of the hexagonally close‐packed UiO‐66 metal–organic framework is assembled as a Langmuir monolayer at liquid interfaces using preformed metal oxo clusters and tailor‐made organic linkers. Coordination‐driven self‐assembly governs film formation, while linker amphiphilicity confines growth to two dimensions.
Ajmal Roshan Unniram Parambil, Muhammed Jibin Parammal, Prashant Hitaishi, Seyed Amirabbas Nazemi, Narmadha Devi Suresh Kumar, Alla Sologubenko, Stephan Handschin, Bridget M. Murphy, Thomas A. Jung, Jonathan De Roo, Patrick Shahgaldian   +10 more
wiley   +1 more source

Improved neutral lipid production from Tetradesmus obliquus through fed-batch mixotrophic cultivation at high pH using potato peel hydrolysate. [PDF]

Sci Rep
Gomaa M, Mohamed AKSH, Youssef AM, El-Shanawany AA.   +3 more
europepmc   +1 more source

Drug Delivery Systems for Resiquimod to Control Myeloid‐Derived Suppressor Cells in Cancer Immunotherapy

WIREs Nanomedicine and Nanobiotechnology, Volume 18, Issue 2, March/April 2026.
Myeloid‐derived suppressor cells (MDSCs) are key contributors to cancer immunotherapy failure and major targets in new therapeutic strategies. We highlight therapeutic approaches to counteract their immunosuppressive functions and discuss recent efforts to optimize drug delivery for controlling MDSCs, focusing on resiquimod as a representative drug ...
Yanying He, Yoon Yeo
wiley   +1 more source

Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome. [PDF]

Brain
Thomma RCM, Halstead SK, de Koning LC, Wiegers EJA, Gourlay DS, Tio-Gillen AP, van Rijs W, Andersen H, Antonini G, Arends S, Attarian S, Barroso FA, Bateman KJ, Benedetti L, Van den Bergh P, Bürmann J, Busby M, Casasnovas C, Dardiotis E, Davidson A, Feasby TE, Fehmi J, Galassi G, Garcia-Sobrino T, Granit V, Gutiérrez-Gutiérrez G, Hadden RDM, Harbo T, Hartung HP, Hasan I, Holt JKL, Islam Z, Karafiath S, Katzberg HD, Kolb N, Kusunoki S, Kuwabara S, Kuwahara M, Lehmann HC, Leonhard SE, Martín-Aguilar L, Monges S, Nobile-Orazio E, Pardo J, Pereon Y, Querol L, Reisin RC, Rinaldi S, Ripellino P, Roberts RC, Scheidegger O, Shahrizaila N, Sheikh KA, Silvestri NJ, Sindrup SH, Stein B, Tan CY, Tankisi H, Visser LH, Waheed W, Huizinga R, Jacobs BC, Willison HJ, IGOS consortium .   +63 more
europepmc   +1 more source